adalimumab-fkjp Hulio

Selected indexed studies

• Performance evaluation of an adalimumab biosimilar autoinjector and its reference device: comparative use human factors study in patients with rheumatoid arthritis and juvenile idiopathic arthritis. (Drug Deliv, 2026) [PMID:41874604]

_Worker-drafted node — pending editorial review._